Lucas Ward
Stock Analyst at Ascendiant
(0.03)
# 4,356
Out of 4,357 analysts
54
Total ratings
12.3%
Success rate
-54.1%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIQT LiqTech International | Maintained: Buy | $4.3 → $4.4 | $1.10 | +300.00% | 10 | May 20, 2026 | |
| VVOS Vivos Therapeutics | Reiterated: Buy | $5.5 → $3 | $0.70 | +328.57% | 11 | Apr 22, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Rated: Buy | $11 → $4.2 | $1.49 | +181.88% | 9 | Apr 9, 2026 | |
| ACON Aclarion | Rated: Buy | $23 → $7 | $3.28 | +113.41% | 7 | Mar 25, 2026 | |
| HSCS HeartSciences | Maintained: Buy | $9.2 → $8 | $1.67 | +379.04% | 12 | Mar 23, 2026 | |
| VMAR Vision Marine Technologies | Maintained: Buy | $30 → $10 | $0.599 | n/a | 5 | Apr 30, 2025 |
LiqTech International
May 20, 2026
Maintained: Buy
Price Target: $4.3 → $4.4
Current: $1.10
Upside: +300.00%
Vivos Therapeutics
Apr 22, 2026
Reiterated: Buy
Price Target: $5.5 → $3
Current: $0.70
Upside: +328.57%
60 Degrees Pharmaceuticals
Apr 9, 2026
Rated: Buy
Price Target: $11 → $4.2
Current: $1.49
Upside: +181.88%
Aclarion
Mar 25, 2026
Rated: Buy
Price Target: $23 → $7
Current: $3.28
Upside: +113.41%
HeartSciences
Mar 23, 2026
Maintained: Buy
Price Target: $9.2 → $8
Current: $1.67
Upside: +379.04%
Vision Marine Technologies
Apr 30, 2025
Maintained: Buy
Price Target: $30 → $10
Current: $0.599
Upside: n/a